Literature DB >> 33245475

Region-selective permeability of the blood-brain barrier to α-aminoisobutyric acid during thiamine deficiency and following its reversal.

Alan S Hazell1, Roger F Butterworth2.   

Abstract

Thiamine deficiency (TD) results in focal lesions in several regions of the rat brain including the thalamus and inferior colliculus. Since alterations in blood-brain barrier (BBB) integrity may play a role in this damage, we have examined the influence of TD on the unidirectional blood-to-brain transfer constant (Ki) of the low molecular weight species α-aminoisobutyric acid (AIB) in vulnerable and non-vulnerable brain regions at different stages during progression of the disorder, and following its reversal with thiamine. Analysis of the regional distribution of Ki values showed early (day 10) increased transfer of [14C]-AIB across the BBB in the vulnerable medial thalamus as well as the non-vulnerable caudate and hippocampus. At the acute symptomatic stage (day 14), more widespread BBB permeability changes were detected in most areas including the lateral thalamus, inferior colliculus, and non-vulnerable cerebellum and pons. Twenty-four hours following thiamine replenishment, a heterogeneous pattern of increased BBB permeability was observed in which many structures maintained increased uptake of [14C]-AIB. No increase in the [3H]-dextran space, a marker of intravascular volume, was detected in brain regions during the progress of TD, suggesting that BBB permeability to this large tracer was unaffected. These results indicate that BBB opening i) occurs early during TD, ii) is not restricted to vulnerable areas of the brain, iii) is progressive, iv) persists for at least 24 h following treatment with thiamine, and v) is likely selective in nature, depending on the molecular species being transported.

Entities:  

Keywords:  Blood-brain barrier; Neurodegeneration; Thiamine; Thiamine deficiency; Wernicke’s encephalopathy; α-Aminoisobutyric acid

Year:  2020        PMID: 33245475     DOI: 10.1007/s11011-020-00644-w

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  54 in total

Review 1.  Structure and function of the blood-brain barrier.

Authors:  N Joan Abbott; Adjanie A K Patabendige; Diana E M Dolman; Siti R Yusof; David J Begley
Journal:  Neurobiol Dis       Date:  2009-08-05       Impact factor: 5.996

Review 2.  Thiamine deficiency: an update of pathophysiologic mechanisms and future therapeutic considerations.

Authors:  Eman Abdou; Alan S Hazell
Journal:  Neurochem Res       Date:  2014-10-09       Impact factor: 3.996

3.  Up-regulation of caveolin-1 and blood-brain barrier breakdown are attenuated by N-acetylcysteine in thiamine deficiency.

Authors:  Elizabeth Beauchesne; Paul Desjardins; Roger F Butterworth; Alan S Hazell
Journal:  Neurochem Int       Date:  2010-09-21       Impact factor: 3.921

Review 4.  Astrocyte-endothelial interactions and blood-brain barrier permeability.

Authors:  N Joan Abbott
Journal:  J Anat       Date:  2002-06       Impact factor: 2.610

5.  Transport of alpha-aminoisobutyric acid across brain capillary and cellular membranes.

Authors:  R G Blasberg; J D Fenstermacher; C S Patlak
Journal:  J Cereb Blood Flow Metab       Date:  1983-03       Impact factor: 6.200

6.  Low energy levels in thiamine-deficient encephalopathy.

Authors:  H Aikawa; I S Watanabe; T Furuse; Y Iwasaki; E Satoyoshi; T Sumi; T Moroji
Journal:  J Neuropathol Exp Neurol       Date:  1984-05       Impact factor: 3.685

7.  Altered expression of tight junction proteins and matrix metalloproteinases in thiamine-deficient mouse brain.

Authors:  Elizabeth Beauchesne; Paul Desjardins; Alan S Hazell; Roger F Butterworth
Journal:  Neurochem Int       Date:  2009-04-05       Impact factor: 3.921

8.  Stimulation of phospholipase A2 activity by oxygen-derived free radicals in isolated brain capillaries.

Authors:  A M Au; P H Chan; R A Fishman
Journal:  J Cell Biochem       Date:  1985       Impact factor: 4.429

Review 9.  The blood-brain barrier: an overview: structure, regulation, and clinical implications.

Authors:  Praveen Ballabh; Alex Braun; Maiken Nedergaard
Journal:  Neurobiol Dis       Date:  2004-06       Impact factor: 5.996

10.  eNOS gene deletion restores blood-brain barrier integrity and attenuates neurodegeneration in the thiamine-deficient mouse brain.

Authors:  Elizabeth Beauchesne; Paul Desjardins; Alan S Hazell; Roger F Butterworth
Journal:  J Neurochem       Date:  2009-08-17       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.